Latest / Bloomberg Intelligence / Capital One, Amex Shares Sink on Trump’s Credit-Card Threat
Transcript
- 0:00Speaker 1: Bloomberg Audio Studios, podcasts, radio news. You're listening to the
- 0:10Speaker 1: Bloomberg Intelligence podcast. Catch us live weekdays at ten am
- 0:14Speaker 1: Eastern on Apple, Cocklay and Android Auto with the Bloomberg
- 0:17Speaker 1: Business app. Listen on demand wherever you get your podcasts,
- 0:21Speaker 1: or watch us live on YouTube.
- 0:24Speaker 2: I look at the Bloomberg terminal and the top story
- 0:26Speaker 2: all morning long has been about shares of Capital One
- 0:29Speaker 2: AMEX tumbling, along with some other banks that issue credit cards,
- 0:34Speaker 2: following President Trump's announcement that he is calling on these
- 0:37Speaker 2: companies to cap interest rates at ten percent a year,
- 0:41Speaker 2: which could threaten their profits billions in profits for the industry.
- 0:45Speaker 3: Let's bring in now, Nathan Dean.
- 0:47Speaker 2: Nathan is our senior policy analyst at Bloomberg Intelligence, and Nathan,
- 0:50Speaker 2: one thing that we need to make clear, President Trump
- 0:53Speaker 2: calling for this is not the same as him actually
- 0:55Speaker 2: having authority to do this. Is this something in which
- 0:58Speaker 2: he has the authority to call for a cap on
- 1:01Speaker 2: interest rates for credit card companies?
- 1:04Speaker 4: No, it's not, And that should be the first question
- 1:06Speaker 4: that these investors look at is how would President Trump
- 1:08Speaker 4: implement this? Because look, he said that in effective January twentieth,
- 1:12Speaker 4: that there would be a one year cap at ten percent,
- 1:14Speaker 4: but really there's no way that he can implement this.
- 1:17Speaker 4: There has been legislation from Senators Bernie Sanders the Independent,
- 1:20Speaker 4: and obviously Josh Holly the Republican to actually put in
- 1:24Speaker 4: a cap for five years, but that legislation really hasn't
- 1:27Speaker 4: gone anywhere. Now, the industry averages around twenty one percent.
- 1:30Speaker 4: Going down to ten percent, obviously you're going to see
- 1:32Speaker 4: a significant decline in what the interest would be to
- 1:34Speaker 4: these banks, and obviously that we're starting to see what
- 1:38Speaker 4: the potential of that would be in the stock market.
- 1:40Speaker 4: But you know our note that we put out the
- 1:42Speaker 4: clients this morning, he said, look, we only see a
- 1:43Speaker 4: thirty percent chance of this happening in twenty twenty six.
- 1:46Speaker 4: The more likely scenario is that President Trump uses the regulators. Ironically,
- 1:50Speaker 4: it would be one of the consumer the Consumer Financial
- 1:52Speaker 4: Protection Bureau, the regulator that they've been moving to get
- 1:55Speaker 4: rid of. But they would use the regulators in the
- 1:57Speaker 4: bully pulpit to pressure these firms to actually lower interest
- 2:00Speaker 4: rates on their own. But after that, you know, these
- 2:02Speaker 4: credit card company banks, they can continue to operate as is.
- 2:05Speaker 5: Let's say this policy actually did go into fact in
- 2:08Speaker 5: terms of timeline, how long would it take for some
- 2:11Speaker 5: of these companies to actually cap their rates.
- 2:15Speaker 6: So it'd be fairly quickly.
- 2:16Speaker 4: I mean, obviously it wouldn't be so much an operational
- 2:18Speaker 4: standpoint of capping the rate at ten percent, But the
- 2:22Speaker 4: question would be what are you going to do with
- 2:23Speaker 4: the credit risk that comes out of that, because you
- 2:26Speaker 4: know a lot of these reward programs think of those
- 2:28Speaker 4: you know, those fancy lounges at JFK and at DCA
- 2:31Speaker 4: and Reagan. You know, a lot of that is paid
- 2:33Speaker 4: for by the fact that you have high quality credit
- 2:36Speaker 4: and you have low quality credit consumers as part of this,
- 2:39Speaker 4: and so one of the note that we put on
- 2:42Speaker 4: in the morning this morning showed that if you were
- 2:44Speaker 4: to curred the tail this down to ten percent, banks
- 2:46Speaker 4: would be a little bit more choosy about who they
- 2:48Speaker 4: are offering credit to. You would actually see a decline
- 2:51Speaker 4: in terms of the number of users or credit cards,
- 2:53Speaker 4: which ultimately could have a small impact on Visa, MasterCard
- 2:56Speaker 4: and so forth. But a lot of those reward programs
- 2:58Speaker 4: that people enjoy would likely dry up as well, which
- 3:01Speaker 4: is not something that I think a lot of the
- 3:02Speaker 4: American populace would want to see, especially during an election year.
- 3:06Speaker 2: Yeah, especially since they already paid the eight hundred and
- 3:08Speaker 2: ninety five dollars and ho fee and want to get
- 3:10Speaker 2: something for it. Nathan, you mentioned that there has been
- 3:12Speaker 2: legislation proposed to target these interesst rate levels at these
- 3:17Speaker 2: credit card issuers. Now that President Trump has made this
- 3:20Speaker 2: something of a rallying cry, do you think that that
- 3:24Speaker 2: legislation will have more of a chance of getting anywhere?
- 3:27Speaker 7: So?
- 3:27Speaker 4: You know, normally I would say more so in twenty
- 3:29Speaker 4: twenty seven, less so in twenty twenty six. The reason
- 3:31Speaker 4: being is in an election year. And look, when President
- 3:34Speaker 4: Trump proposed there are a lot of Democrats on Capitol
- 3:36Speaker 4: Hill that actually would be in favor of this. You
- 3:38Speaker 4: want to cap credit card interest rates at ten percent,
- 3:40Speaker 4: You could probably get a significant number of Democrats to say, yeah,
- 3:43Speaker 4: we're on board. But the problem here for the president
- 3:46Speaker 4: is that there's probably an unspoken Republican populace. And I'm
- 3:49Speaker 4: specifically looking at the House Financial Services Committee and the
- 3:52Speaker 4: Senate Banking Committe at the moment that have bank allies
- 3:54Speaker 4: that are completely against this move. And so what I
- 3:57Speaker 4: think will happen is is that if President Trump said
- 4:00Speaker 4: that we want to push this legislation. And if the
- 4:03Speaker 4: folks on the Senate side say, look, we want to
- 4:04Speaker 4: work on this legislation, the most step that you would
- 4:07Speaker 4: have is have a hearing to talk about that legislation.
- 4:09Speaker 4: So hearing plus debate, plus negotiations plus an election year,
- 4:13Speaker 4: that just is in a timeline to get it done
- 4:15Speaker 4: before November twenty twenty six. I think the real risk
- 4:18Speaker 4: is if you see this in twenty twenty seven, but
- 4:19Speaker 4: by then, you know this issue may be moot and
- 4:22Speaker 4: off the President's mindset.
- 4:24Speaker 5: Nathan, I'm just looking at the market reaction here from
- 4:26Speaker 5: some of these credit card issuers, Capital One, American Express,
- 4:30Speaker 5: just their share prices falling more substantially than some of
- 4:33Speaker 5: the banks like JP Morgan. How much more significant would
- 4:36Speaker 5: the impact be on these credit card issuers versus say,
- 4:40Speaker 5: the big banks that are also issuing credit cards.
- 4:43Speaker 4: Well, it's a story of diversification in revenue. I mean
- 4:45Speaker 4: the Capital One, the American Express, you know, the credit
- 4:48Speaker 4: card issuers. You know, it certainly drives higher bulk of
- 4:51Speaker 4: their revenue than it thinks of like the JP Morgans
- 4:53Speaker 4: and Bank Americas which have investment banking, commercial banking and
- 4:56Speaker 4: other types of operations. And that's part of the reason
- 4:59Speaker 4: why policy risks is hitting these companies more so than
- 5:01Speaker 4: others is because you know, if you look at Capital
- 5:04Speaker 4: one in an American Express in particular, you know there's less
- 5:06Speaker 4: of a deregulatory story to tell than what you're seeing
- 5:09Speaker 4: in the big banks at the moment. You know, when
- 5:12Speaker 4: they say that deregulation for the banking industry is coming,
- 5:14Speaker 4: they're most likely saying deregulation is coming for those big
- 5:17Speaker 4: banks in terms of capital requirements of returning towards those banks.
- 5:21Speaker 4: You know, Capital One in Americans Express have a different
- 5:23Speaker 4: type of operating model and as a result, this issue
- 5:25Speaker 4: in particular is more exposed. But I would just say,
- 5:28Speaker 4: is that risk for these companies continue because it's a
- 5:31Speaker 4: Republican issue, it's a democratic issue, and as a result,
- 5:34Speaker 4: this bipartisan issue is going to continue. In the headlines, Nathan.
- 5:37Speaker 2: Before we let you go just very quickly here, Senator
- 5:39Speaker 2: Tom tillis pushing back against this idea of the President
- 5:44Speaker 2: targeting J.
- 5:45Speaker 3: Powell and the Federal Reserve.
- 5:46Speaker 2: He says he will oppose any off Trump's FED nominees,
- 5:49Speaker 2: including the chair until this issue is resolved with regards
- 5:53Speaker 2: to the criminal indictment that's been threatened against the Fed.
- 5:57Speaker 2: You think that will have an impact on the President
- 6:00Speaker 2: on the White House.
- 6:01Speaker 4: It will if Senator Thomas falls through with it, and
- 6:04Speaker 4: it will depending on what his definition resolved is because
- 6:07Speaker 4: the Senate Banking Committee is thirteen to eleven and he
- 6:09Speaker 4: can effectively jam that nomination up.
- 6:12Speaker 2: Stay with us. More from Bloomberg Intelligence coming up after this.
- 6:18Speaker 1: You're listening to the Bloomberg Intelligence podcast. Catch us live
- 6:22Speaker 1: weekdays at ten am Eastern on Apple, Cocklay and Android
- 6:25Speaker 1: Auto with the Bloomberg Business App. Listen on demand wherever
- 6:28Speaker 1: you get your podcasts, or watch us live on YouTube.
- 6:33Speaker 5: Scarlett, it looks like we have Lululemon rising as holiday
- 6:36Speaker 5: sales show signs of a rebound. To explain that we
- 6:39Speaker 5: have Punam Goyle. She is senior US Commerce and Retail
- 6:42Speaker 5: analyst at Bloomberg Intelligence Poonham. I'm not a big Lululemon shopper,
- 6:47Speaker 5: so it was only recently that I discovered that they
- 6:49Speaker 5: actually have a membership, which is really interesting. I can't
- 6:52Speaker 5: help but wonder what is this loyalty program? How does
- 6:56Speaker 5: it influence repeat purchase behavior and margins for the company.
- 7:00Speaker 8: Yeah, so the loyalty program is not something that Lulu
- 7:04Speaker 8: Lemon has had for a long long time, but it
- 7:07Speaker 8: does help, just like with any other loyalty program. You know,
- 7:10Speaker 8: it gives you perks, You have access to lul Lemon merchandise,
- 7:14Speaker 8: you have access to Little Lemon events, et cetera. And
- 7:18Speaker 8: it does bring the member who enjoys the Little Lemon
- 7:21Speaker 8: experience to keep coming back. It's an added reward for
- 7:25Speaker 8: those who have been loyal to the company. But make
- 7:29Speaker 8: no mistakes, that is not what's going to drive the turnaround.
- 7:32Speaker 8: Their turnaround needs a lot more than that.
- 7:35Speaker 2: Yeah, I mean, loyalty programs are something that most brands
- 7:38Speaker 2: have and Lulua Lemon has some more structural issues. Let
- 7:42Speaker 2: me just jump in here because we have a headline
- 7:43Speaker 2: showing than Alphabet when it rose as much as one
- 7:46Speaker 2: point seven percent, it actually surpass four trillion dollars in
- 7:49Speaker 2: market value. This comes after Apple reportedly has chosen Alphabet's
- 7:55Speaker 2: Gemini to run its aipowered.
- 7:57Speaker 3: Sery this year. That's according to CNBC. Put On, let
- 8:00Speaker 3: me get back to you here.
- 8:01Speaker 2: When it comes to Lululemon, separate from the loyalty program,
- 8:04Speaker 2: Lulu has pre announced fourth quarter sales and it comes
- 8:07Speaker 2: in at the higher end of its guidance. This is
- 8:09Speaker 2: kind of surprising because Lulu Lemon has struggled to connect
- 8:12Speaker 2: with choppers the last couple of quarters.
- 8:15Speaker 8: Yes, you can say that it's surprising, but at the
- 8:18Speaker 8: end of the day, the sales are still down. The
- 8:20Speaker 8: estimate was for sales to be down negative one to
- 8:23Speaker 8: three percent, so maybe you're close to minus one. That's
- 8:26Speaker 8: still now where we expect Lemon to be. This doesn't
- 8:29Speaker 8: tell me that the turnaround is you know, has started
- 8:33Speaker 8: and is underway and things wil begin to improve quarter
- 8:36Speaker 8: after quarter. I think it's good, but I need a
- 8:40Speaker 8: lot more to be confident that the turnaround will begin
- 8:42Speaker 8: to take place.
- 8:44Speaker 5: What are some of the macroeconomic trend trends that are
- 8:47Speaker 5: driving Lululemon's customer base.
- 8:49Speaker 3: Is it inflation?
- 8:50Speaker 5: Is it just an overall change in discretionary spending patterns?
- 8:54Speaker 6: What is it?
- 8:56Speaker 8: Yeah, so the macro economy has been you know, good
- 8:59Speaker 8: and bad. Consumer has been doing well. Little Lemon, you
- 9:02Speaker 8: could argue sits in the affluent space of activewear. But
- 9:07Speaker 8: that said, it's not that the customer is pressured and
- 9:10Speaker 8: that's why their sales have fallen. It is that they
- 9:12Speaker 8: have lacked innovation and execution has been weak. So the
- 9:17Speaker 8: key here is a company specific issue that they need
- 9:20Speaker 8: to resolve, and they are working towards it. We will
- 9:24Speaker 8: be getting a new CEO, hopefully at some point in
- 9:26Speaker 8: twenty twenty six, and it'll really be then where we
- 9:29Speaker 8: can see who comes in, what's the strategy, and how
- 9:32Speaker 8: does lulle Lemon re engage. It's for a customer that
- 9:37Speaker 8: probably still loves the brand but just hasn't found enough
- 9:40Speaker 8: new to keep going back and back.
- 9:43Speaker 7: Yeah.
- 9:43Speaker 3: Absolutely.
- 9:44Speaker 2: I think about the competitors that Lululemon faces in the space.
- 9:47Speaker 2: It ranges from Jerry to all the other big names
- 9:51Speaker 2: out there, including Nike, which offers perhaps similar at leisure
- 9:54Speaker 2: wear but at a lower price point too. When it
- 9:57Speaker 2: comes to this new CEO, Calvin McDonald, the currency is
- 9:59Speaker 2: such as step down at the end of January, and
- 10:02Speaker 2: I know Elliott has been a big player in pushing
- 10:04Speaker 2: for Jane Nielsen, the former CFO at Ralph Lauren, to
- 10:06Speaker 2: replace him. What's the latest on that. Do we presume
- 10:10Speaker 2: that Jan Nielsen is going to be the next CEO?
- 10:14Speaker 8: I mean we don't know yet right, so it's definitely
- 10:17Speaker 8: one of the contenders and could be. And I think
- 10:20Speaker 8: as long as they get a product led executive, which
- 10:23Speaker 8: he is, Little Lemon could be in good hands to
- 10:26Speaker 8: continue this turnaround.
- 10:29Speaker 2: So founder Chip Wilson is also kind of involved here.
- 10:33Speaker 2: That's another name that we haven't heard from in a while.
- 10:35Speaker 2: He founded the company. He no longer sits on the board,
- 10:38Speaker 2: but he still owns about nine percent of the stock.
- 10:41Speaker 2: How much do you pay attention to what he says?
- 10:44Speaker 8: Who know, we definitely look at it. Look what he
- 10:47Speaker 8: said was important. He counted the company, the company was
- 10:50Speaker 8: grounded on innovation, on products, and I think he makes
- 10:54Speaker 8: fair points that the company needs to kind of really
- 10:59Speaker 8: re engage to the customer and go back to its roots,
- 11:02Speaker 8: which is are you still ahead of the competition? Like
- 11:05Speaker 8: you know you mentioned earlier competition has increased, and it has,
- 11:08Speaker 8: but competition was always there. But where is Little Lemon
- 11:12Speaker 8: ahead of it? Can you get similar at leisure pants
- 11:14Speaker 8: or leggings at Vori or at Aloe or at Leta.
- 11:19Speaker 8: How does Little Lemon stand out today? And that's the
- 11:21Speaker 8: big question that they need to answer.
- 11:23Speaker 5: Punam What might be the next drivers of revenue growth
- 11:27Speaker 5: for Lululemon.
- 11:29Speaker 7: It's all product.
- 11:31Speaker 8: I think you know, they are engaging in new product innovation,
- 11:34Speaker 8: and as we see that roll out and see that resonate,
- 11:38Speaker 8: we think that is what will drive back traffic. Little
- 11:41Speaker 8: Lemon was a store in the mall that for me
- 11:44Speaker 8: was like Apple right, no matter how dead the mall was,
- 11:47Speaker 8: the store had people in it. Today when I walk in,
- 11:51Speaker 8: that is not the case. So to see that comeback
- 11:53Speaker 8: is going to be driven by two things. In my mind,
- 11:56Speaker 8: one is execution and the other is product.
- 11:59Speaker 3: Stay with us from Bloomberg Intelligence coming up after this.
- 12:05Speaker 1: You're listening to the Bloomberg Intelligence podcast. Catch us live
- 12:09Speaker 1: weekdays at ten am Eastern on Apple, Cocklay and Android
- 12:12Speaker 1: Auto with the Bloomberg Business App. Listen on demand wherever
- 12:16Speaker 1: you get your podcasts, or watch us live on YouTube.
- 12:20Speaker 2: I'm Scarlett Foo and we've got some news about the
- 12:23Speaker 2: top AI company, kind of the poster child for AI,
- 12:26Speaker 2: in Vidia teaming up with the top pharma name Eli Lilly.
- 12:30Speaker 2: The two are going to work together within Nvidia investing
- 12:33Speaker 2: a billion dollars into an AI drug laboratory. What does
- 12:36Speaker 2: that mean? What are they going to use it? For
- 12:38Speaker 2: Let's bring in Sam Fizzelli. He has Bloomberg Intelligence's director
- 12:41Speaker 2: of Research for Global Industries and senior pharmaceuticals analysts. He
- 12:44Speaker 2: always gives us his read on the biotech sector. Sam,
- 12:48Speaker 2: good to speak with you. How do you make sense
- 12:50Speaker 2: of this headline in Vidia investing a billion dollars in
- 12:53Speaker 2: an AI drug lab with Eli Lilly got it.
- 12:57Speaker 9: Very nice to talk to you again today. Look, I
- 13:00Speaker 9: think these are the brillion dollar club getting together.
- 13:03Speaker 7: A billion dollars is probably dropping.
- 13:05Speaker 9: The ocean for both of them is over five years,
- 13:08Speaker 9: and I think the aim of this, at the end
- 13:12Speaker 9: of the day is to try and automate and speed
- 13:14Speaker 9: up as much of the partly the drudgery of doing
- 13:19Speaker 9: lab work, because lab work just like as if you
- 13:21Speaker 9: were a doctor in a clinical setting, you need to
- 13:25Speaker 9: take a lot of notes, a lot of details. But
- 13:27Speaker 9: at the same time, I think they're investing in what
- 13:30Speaker 9: appears to be automating twenty four to seven experiments, things
- 13:34Speaker 9: that human beings just can't do. And I know, having
- 13:38Speaker 9: been a scientist, that sometimes your life is on hold
- 13:41Speaker 9: because you have to go back and deal with your experiments, yourselves,
- 13:45Speaker 9: or whatever it is that you're running, So a lot
- 13:47Speaker 9: of these things I think could speed up and also
- 13:49Speaker 9: make the life of the scientists.
- 13:50Speaker 7: A little bit easier.
- 13:51Speaker 9: At the end of the day, though, I think the
- 13:53Speaker 9: aim here is to try and get scientific discoveries translated
- 13:57Speaker 9: to drugs quicker and get them to mark quicker.
- 14:02Speaker 5: Sam. What does this mean for ELI Lilly's rivals? Do
- 14:05Speaker 5: you expect that we'll see some of its competitors also
- 14:08Speaker 5: ramp up their AI endeavors given its partnership with the
- 14:11Speaker 5: company like Nvidia.
- 14:13Speaker 7: Well a lot of pretty much all pharma companies.
- 14:16Speaker 9: Then I just want to point you to a recent
- 14:18Speaker 9: survey that EI Bloomberg Intelligence has done that looked at
- 14:22Speaker 9: ten different industries, one of which being the pharmaceutical industry,
- 14:27Speaker 9: asked executives, what are you doing with this?
- 14:29Speaker 7: What are you trying to get to? What is the aim?
- 14:31Speaker 7: At the end? Everybody is at this.
- 14:33Speaker 9: This is not something specific to Lily and you know Google,
- 14:37Speaker 9: for example, has has through Deep Mind, has created an
- 14:41Speaker 9: ergentic AI called Google Scientists. Is like I think four
- 14:45Speaker 9: agents or five agents who interact with each other and
- 14:47Speaker 9: check each other's hypothesis.
- 14:49Speaker 7: So a lot of this is going on.
- 14:51Speaker 9: In all companies, but of course, here we have Lily,
- 14:54Speaker 9: one of the richest farmer companies around in terms of
- 14:56Speaker 9: the amount of cash browd that's got really being able
- 14:59Speaker 9: to who spend the money with that really impacting it.
- 15:04Speaker 7: It's balance sheet and cash flow.
- 15:05Speaker 9: And I'm pretty sure everybody's at this, but really this
- 15:08Speaker 9: is the Newstjule if you like absolutely.
- 15:11Speaker 2: Like you said, it's a drop in the bucket for
- 15:13Speaker 2: both of these companies. But when you have a number
- 15:15Speaker 2: like one billion dollars and these big brand names, it
- 15:18Speaker 2: gets people's attention. What also gets my attention, Sam, is Maderna.
- 15:22Speaker 2: Maderna obviously one of the vaccine makers during the pandemic,
- 15:27Speaker 2: but it's had a rough go at it recently because
- 15:30Speaker 2: it's so dependent on these vaccines and we have an
- 15:33Speaker 2: administration that is kind of anti vaccine right now. Yet
- 15:37Speaker 2: madernal pre announced at the JP Morgan Healthcare conference that
- 15:39Speaker 2: it's US COVID business did better than expected.
- 15:43Speaker 3: Is Maderna starting to stabilize.
- 15:46Speaker 7: Well, one would hope.
- 15:48Speaker 9: So that's stuck with their aim of growing twenty twenty
- 15:52Speaker 9: six point ten percent.
- 15:54Speaker 7: But you know, if you look back at the beginning
- 15:56Speaker 7: of the year, where.
- 15:57Speaker 9: The company in twenty twenty five started with guidance and
- 16:01Speaker 9: where we ended up, we're a good five six hundred
- 16:04Speaker 9: million dollars short of what the hope was at the
- 16:06Speaker 9: beginning of the year. So everybody, I think it knows
- 16:09Speaker 9: that this is a very difficult market to call for
- 16:11Speaker 9: exactly the reasons you just highlighted. There is a constant
- 16:15Speaker 9: change in the way that the administration in the US
- 16:17Speaker 9: and not just the US elsewhere is also dealing with vaccination,
- 16:22Speaker 9: particularly in the COVID side of things. Other vaccinations are
- 16:25Speaker 9: still pretty much well settled and at least outside the US.
- 16:30Speaker 9: The problem was so that MODERNA is going to face
- 16:33Speaker 9: or has been facing, is that there are lots of
- 16:35Speaker 9: people that I think my patent colleagues say there at
- 16:37Speaker 9: this twenty various directions of legal cases or trials going
- 16:44Speaker 9: on different groups saying you're infringing my patterns, so you
- 16:48Speaker 9: in fringe my patterns, and you need.
- 16:49Speaker 7: To because there was billions and billions of dollars revenues.
- 16:53Speaker 9: So some of that is coming potentially in the March timeframe,
- 16:57Speaker 9: pretty lightly against a trial coming up against our breaches
- 17:02Speaker 9: another company that's listed in the US. So some of
- 17:04Speaker 9: that is I think something that might keep people from
- 17:07Speaker 9: getting too excited about modern as guidance today.
- 17:10Speaker 3: Sam very quickly.
- 17:11Speaker 5: Obviously, the end of the pandemic has made it hard
- 17:13Speaker 5: for pharmaceutical companies US officials curbing the people who are
- 17:18Speaker 5: eligible for them. What then, are the next growth catalysts
- 17:21Speaker 5: for vaccine makers?
- 17:23Speaker 9: Oh, well, I think a lot of these companies are
- 17:26Speaker 9: trying to use the technology, which is the mRNA technology,
- 17:29Speaker 9: those with an mRNA technology to develop cancer therapies.
- 17:33Speaker 7: You remember, at the end of the day, what you're
- 17:35Speaker 7: trying to do is get an.
- 17:36Speaker 9: Immune response, which is what vaccines do against something relatively
- 17:40Speaker 9: foreign in infectious diseases Eca virus. In cancer, you're trying
- 17:45Speaker 9: to get cancers that's killed and recognized by the immune system.
- 17:48Speaker 7: That's where these guys are great.
- 17:50Speaker 3: Stay with us. More from Bloomberg Intelligence coming up after this.
- 17:56Speaker 1: You're listening to the Bloomberg Intelligence podcast live weekdays at
- 18:01Speaker 1: ten am. He's done on Apple, Cocklay and Android Auto
- 18:03Speaker 1: with the Bloomberg Business app. Listen on demand wherever you
- 18:07Speaker 1: get your podcasts, or watch us live on YouTube.
- 18:10Speaker 6: You know the Bonnie Rate song I Don't I Can't
- 18:13Speaker 6: Make You Love Me?
- 18:14Speaker 5: You have to sing it for us?
- 18:15Speaker 6: Well, no, I'll spare you that. I feel like that's
- 18:18Speaker 6: how Paramounts sky dances. Feeling that dramas is never ending,
- 18:24Speaker 6: they made some new moves to try and get Warner
- 18:26Speaker 6: Brothers to dump Netflix and choose them. And Keith Ranganathan
- 18:30Speaker 6: with Bloomberg Intelligence is here. She's going to try to
- 18:33Speaker 6: sort this out for us. Do I sense a desperation
- 18:36Speaker 6: on the part of Paramount's sky dance. It seems not
- 18:40Speaker 6: the cost of getting Warner Brothers, but the cost of
- 18:43Speaker 6: not getting Warner Brothers, that's the big issue.
- 18:46Speaker 10: Yeah, absolutely, John, You're absolutely right. And this is the truth.
- 18:50Speaker 10: This is the hard hitting truth for really all of
- 18:52Speaker 10: these legacy media companies, right, you know, how much are
- 18:56Speaker 10: they going to lose out if Netflix actually does go up,
- 19:00Speaker 10: you know, end up winning this whole bidding war for
- 19:03Speaker 10: Warner Brothers. And that's really what we see today from
- 19:05Speaker 10: Paramount basically, you know, uh, the whole letter to shareholders
- 19:11Speaker 10: as well as the legal the lawsuit that they've that
- 19:15Speaker 10: they just filed basically threatening a proxy fight. So things
- 19:18Speaker 10: are kind of getting very very interesting, somewhat I would say,
- 19:22Speaker 10: even somewhat ugly.
- 19:23Speaker 5: Jifah, I'm just reading this report It says that the
- 19:26Speaker 5: lawsuit is aiming to force out into the open more
- 19:29Speaker 5: details about Netflix's takeover agreement. What exactly is this lawsuit alleging?
- 19:35Speaker 5: What is it supposed to do here? And is it
- 19:37Speaker 5: just posturing?
- 19:38Speaker 10: Perhaps it's a yeah, I think it's all of the above, Alex.
- 19:43Speaker 10: So really, what we're you know, so we have one
- 19:46Speaker 10: number which is there for the streaming and the studio assets.
- 19:49Speaker 10: Remember the whole Warner Brothers transaction is about two different
- 19:53Speaker 10: uh units really, so one is the streaming and the
- 19:56Speaker 10: studio assets, and for that we already have a deal
- 19:58Speaker 10: from Netflix for about twenty eight dollars a share. Now,
- 20:02Speaker 10: what is a shear What is really, so to speak,
- 20:05Speaker 10: in the air, so to speak, is the remaining part
- 20:07Speaker 10: of the business, which is the TV network business, what
- 20:11Speaker 10: is called the global networks or Discovery Global. And here
- 20:14Speaker 10: is where, you know, there is a lot of questions
- 20:17Speaker 10: about where exactly that should be valued. So Paramount pretty
- 20:19Speaker 10: much has come out and said that it should be
- 20:21Speaker 10: valued at zero dollars a share. And they base their
- 20:24Speaker 10: argument on the recent trading debut of Versunt, which is
- 20:28Speaker 10: the cable network spinoff from Comcast, which has fared really
- 20:31Speaker 10: really poorly. In its first week, the stock off almost
- 20:35Speaker 10: thirty percent, and so that you know, Paramount kind of
- 20:37Speaker 10: using that as their defense for valuing these Water Brothers
- 20:40Speaker 10: networks next to nothing. Warner Brothers, on the other hand,
- 20:43Speaker 10: obviously internally has a number for those networks. They you know,
- 20:48Speaker 10: according to reports, I think it's worth about three to
- 20:50Speaker 10: four dollars a share. So that's really where a lot
- 20:52Speaker 10: of this discrepancy is kind of stemming from. And what
- 20:55Speaker 10: Paramount is asking in this lawsuit is to really clarify
- 20:59Speaker 10: all of these aspects. What is the stub value, what
- 21:01Speaker 10: is you know, what are all the different financial details
- 21:04Speaker 10: on the Netflix deal, and what is the risk adjusted
- 21:07Speaker 10: uncertainty that you know, Warner Brothers is ascribing to the
- 21:11Speaker 10: thirty dollars offer from Paramount, So they say they're really
- 21:13Speaker 10: asking WBD to kind of spell it all out and
- 21:17Speaker 10: come out in the open.
- 21:18Speaker 6: So, I mean, are they doing this on the cheap? Whint?
- 21:21Speaker 6: It's just pony up more money? Uh Paramount?
- 21:26Speaker 10: Yeah, So you know right now there, you know, offer
- 21:29Speaker 10: is obviously thirty dollars a share, which Warner Brothers has
- 21:32Speaker 10: called inadequate and inferior to the Netflix deal of course,
- 21:38Speaker 10: you know, Paramount keeps arguing that their offer is all
- 21:40Speaker 10: cash versus Netflix, which is you know, partly cash and
- 21:43Speaker 10: partly stock. And you know, the stock is obviously has
- 21:46Speaker 10: been really like it's it's been going down in value,
- 21:51Speaker 10: so again that part of it is a little bit
- 21:52Speaker 10: of a question mark, but really this is you know,
- 21:55Speaker 10: I think ultimately what's going to happen is they are
- 21:57Speaker 10: going to have to sweeten the deal. There is no
- 21:59Speaker 10: doubt about that because we haven't seen a whole lot
- 22:01Speaker 10: of faction in terms of the Warner Brothers shareholders actually
- 22:04Speaker 10: tendering their shares, and that's really what it's going to
- 22:07Speaker 10: come down to. So only about two percent of the
- 22:09Speaker 10: shares have been tendered, which means that the shareholders are
- 22:12Speaker 10: really waiting for a higher bid. So Paramount I think
- 22:16Speaker 10: has to you know, raise the offer ultimately.
- 22:19Speaker 5: Keith, it kind of feels like this bidding war has
- 22:21Speaker 5: no end in sight. We get some new escalation every day.
- 22:24Speaker 5: From a regulatory perspective, perhaps, is there any limitation for
- 22:29Speaker 5: how much longer this can go on? And what does
- 22:32Speaker 5: it do for the terms of the deal for you know,
- 22:35Speaker 5: if it keeps shrogging on much.
- 22:36Speaker 10: Longer, Yeah, it's definitely not good for anybody, right. It
- 22:40Speaker 10: just kind of keeps adding to the uncertainty here. But
- 22:43Speaker 10: in terms of the dates and what we know so far,
- 22:45Speaker 10: January twenty first, so far is the deadline that Paramount
- 22:49Speaker 10: has set for the Warner Brothers Discovery shareholders to tender
- 22:53Speaker 10: their shares. Now, they can very well come back and
- 22:56Speaker 10: extend that deadline, or you know, they may not. They
- 23:00Speaker 10: may choose to walk away from the deal, or they
- 23:02Speaker 10: may you know, choose to raise the offer. So again,
- 23:04Speaker 10: a lot up in the air at this point. Just
- 23:08Speaker 10: it's we're kind of playing a waiting game here, Alex.
- 23:10Speaker 6: What would they what a proxy fight? What would that
- 23:13Speaker 6: look like?
- 23:14Speaker 10: That is going to be really ugly, And I don't think,
- 23:18Speaker 10: you know, obviously that kind of changes a lot of things,
- 23:21Speaker 10: you know. I think the Warner Brothers Discovery shareholders, however,
- 23:26Speaker 10: do believe that the board the management is doing the
- 23:30Speaker 10: right thing. I think they do believe that the Netflix
- 23:33Speaker 10: offer is actually superior, and I think that they do
- 23:35Speaker 10: believe that the TV networks are actually worth something, something
- 23:38Speaker 10: much more than what Paramount is suggesting. So again, I
- 23:43Speaker 10: don't necessarily know that a proxy fight would be productive
- 23:45Speaker 10: for Paramount.
- 23:46Speaker 1: This is the Bloomberg Intelligence Podcast, available on Apple, Spotify,
- 23:51Speaker 1: and anywhere else you get your podcasts. Listen live each weekday,
- 23:55Speaker 1: ten am to noon Eastern on Bloomberg dot com, the
- 23:59Speaker 1: iHeartRadio tune in, and the Bloomberg Business app. You can
- 24:03Speaker 1: also watch us live every weekday on YouTube and always
- 24:07Speaker 1: on the Bloomberg terminal